Contents

Current Pharmaceutical Design, Volume 21 - Number 17

Meet the Editorial Board

, 21(17): 2167

Gregory Y.H. Lip


DOI: 10.2174/138161282117150430124606




Editorial

Editorial (Thematic Issue: Rheumatology: An Evolutionary force in Biologics)

, 21(17): 2168 - 2169

Matthew A. Sleeman


DOI: 10.2174/1381612821999150313162300




Rheumatoid Arthritis: An Evolutionary Force in Biologics

, 21(17): 2170 - 2178

Philip M. Brown and John D. Isaacs


DOI: 10.2174/1381612821666150310141827




Rheumatology: A Force for Change in Monoclonal Antibodies

, 21(17): 2179 - 2186

David C. Lowe and Tristan J. Vaughan


DOI: 10.2174/1381612821666150310142202




Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside

, 21(17): 2187 - 2197

Xiao Liu, Andrew J. Teichtahl and Ian P. Wicks


DOI: 10.2174/1381612821666150310143332




Finding a Place for Interleukin-1 Inhibitors in the Treatment of Rheumatologic Diseases

, 21(17): 2198 - 2205

Donna Finch and Matthew Sleeman


DOI: 10.2174/1381612821666150310144603




Biological Therapies in Osteoarthritis

, 21(17): 2206 - 2215

Claire Y.J. Wenham, Michael McDermott and Philip G. Conaghan


DOI: 10.2174/1381612821666150310144940




Towards a Stratified Targeted Approach with Biologic Treatments in Rheumatoid Arthritis: Role of Synovial Pathobiology

, 21(17): 2216 - 2224

Elisa Astorri, Alessandra Nerviani, Michele Bombardieri and Costantino Pitzalis


DOI: 10.2174/1381612821666150310145758




The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE

, 21(17): 2225 - 2235

Shaun M. Flint, Eoin F. McKinney, Paul A. Lyons and Kenneth G.C. Smith


DOI: 10.2174/1381612821666150313130256




Microrna-21: A Central Regulator of Fibrotic Diseases Via Various Targets

, 21(17): 2236 - 2242

Ying Huang, Yong He and Jun Li


DOI: 10.2174/1381612820666141226095701




25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages

, 21(17): 2243 - 2249

Harald Mangge, Sieglinde Zelzer, Andreas Meinitzer, Ingeborg Stelzer, Wolfgang J. Schnedl, Daniel Weghuber, Dietmar Fuchs, Teodor T. Postolache, Elmar Aigner, Christian Datz and Eva Z. Reininghaus


DOI: 10.2174/1381612821666150105160931




Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design

, 21(17): 2250 - 2258

Janos Tajti, Zsofia Majlath, Delia Szok, Anett Csati, Jozsef Toldi, Ferenc Fulop and Laszlo Vecsei


DOI: 10.2174/1381612821666150105163055




Treatment of Leishmaniasis: A Review and Assessment of Recent Research

, 21(17): 2259 - 2275

Ehab Kotb Elmahallawy and Ahmad Agil


DOI: 10.2174/1381612821666141231163053




CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

, 21(17): 2276 - 2283

Karin Tamas, Urszula M. Domanska, Tonnis H. van Dijk, Hetty Timmer-Bosscha, Klaas Havenga, Arend Karrenbeld, Wim J. Sluiter, Jannet C. Beukema, Marcel A.T.M. van Vugt, Elisabeth G.E. de Vries, Geke A.P. Hospers and Annemiek M.E. Walenkamp


DOI: 10.2174/1381612821666150105155615




Therapeutic Effect of Ghrelin in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis

, 21(17): 2284 - 2290

J. Bukowczan, Z. Warzecha, P. Ceranowicz, B. Kusnierz-Cabala, R. Tomaszewska and A. Dembinski


DOI: 10.2174/1381612821666150105152553




Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

, 21(17): 2291 - 2303

Laszlo G. Harsing Jr., Julia Timar, Geza Szabo, Szabolcs Udvari, Katalin M. Nagy, Bernadett Marko, Gabriella Zsilla, Andrea Czompa, Pal Tapolcsanyi, Akos Kocsis and Peter Matyus


DOI: 10.2174/1381612821666150109125623




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science